Search Knowledge Base

9 results for "deferasirox"

No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis pubmed_article
Evidence Source 2023 PMID: 35878782
Deferasirox for managing iron overload in people with thalassaemia pubmed_article
Evidence Source 2017 PMID: 28809446
Deferasirox for managing iron overload in people with myelodysplastic syndrome pubmed_article
Evidence Source 2014 PMID: 25348770
Deferasirox for managing iron overload in people with thalassaemia pubmed_article
Evidence Source 2012 PMID: 22336831
Deferasirox for managing transfusional iron overload in people with sickle cell disease pubmed_article
Evidence Source 2010 PMID: 20687088
Deferasirox for managing iron overload in people with myelodysplastic syndrome pubmed_article
Evidence Source 2010 PMID: 21069694
Deferasirox for managing transfusional iron overload in people with sickle cell disease pubmed_article
Evidence Source 2014 PMID: 24893174
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia pubmed_article
Evidence Source 2013 PMID: 23963793
Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis pubmed_article
Evidence Source PMID: 29727586

Evidence Search Results semantic · quality-ranked

No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 51 2023 PMID: 35878782 DOI: 10.1016/j.tracli.2022.07.004
Deferasirox for managing iron overload in people with thalassaemia meta_analysis pubmed_article
Quality: 67 2017 PMID: 28809446 DOI: 10.1002/14651858.CD007476.pub3
Deferasirox for managing iron overload in people with thalassaemia meta_analysis pubmed_article
Quality: 66 2012 PMID: 22336831 DOI: 10.1002/14651858.CD007476.pub2
Deferasirox for managing transfusional iron overload in people with sickle cell disease systematic_review pubmed_article
Quality: 62 2010 PMID: 20687088 DOI: 10.1002/14651858.CD007477.pub2
Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 73 2024 PMID: 38334258 DOI: 10.1111/cns.14607
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial rct pubmed_article
Quality: 72 2022 PMID: 36347265 DOI: 10.1016/S0140-6736(22)02083-9
The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials meta_analysis pubmed_article
Quality: 71 2023 PMID: 37762302 DOI: 10.3390/ijms241813999
Efficacy and safety of intravenous ferric carboxymaltose in the treatment of Restless Legs Syndrome: a systematic review and meta-analysis systematic_review pubmed_article
Quality: 58 2024 PMID: 39839869 DOI: 10.3389/fneur.2024.1503342
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors meta_analysis cochrane_review
Quality: 78 2014 PMID: 24990381 DOI: 10.1002/14651858.CD009532.pub2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. cochrane_review cochrane_review
Quality: 64 PMID: 36321557 DOI: 10.1002/14651858.CD014217

View full evidence search →